Rallybio Corporation - Laporan Laba Rugi (TTM)

Rallybio Corporation
US ˙ NasdaqCM ˙ US75120L1008

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Rallybio Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 0 1 1 1 1
Change (%) 100.00 6.35 33.33 -10.26
% of Revenue 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 31 26 40 34 39
Change (%) -16.41 53.69 -13.19 14.86
% of Revenue 10,285.28 4,298.49 6,211.79 4,044.34 5,176.61
Gross Operating Profit -30 -25 -39 -33 -39
Change (%) -17.56 54.82 -13.95 15.50
% of Revenue -10,185.28 -4,198.49 -6,111.79 -3,944.34 -5,076.61
SG&A 21 19 18 17 16
Change (%) -9.20 -4.82 -7.61 -4.09
% of Revenue 7,090.97 3,219.40 2,881.29 1,996.58 2,133.77
R&D 22 22 -13
Change (%) 0.00
% of Revenue 7,471.91 3,735.95 -1,730.62
OpEx 74 67 58 51 42
Change (%) -9.42 -14.07 -11.42 -17.11
% of Revenue 24,848.16 11,253.85 9,093.08 6,040.92 5,579.76
Operating Income -74 -67 -57 -50 -42
Change (%) -9.86 -14.25 -11.92 -17.23
% of Revenue -24,748.16 -11,153.85 -8,993.08 -5,940.92 -5,479.76
Interest Expense
Change (%)
% of Revenue
Net Income -74 -67 -58 -48 -42
Change (%) -9.35 -13.73 -16.60 -13.56
% of Revenue -24,709.36 -11,199.50 -9,084.12 -5,682.19 -5,473.32

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista